Trial Profile
Long-term administration study of KW-6485P for pediatric patients (extension from pharmacokinetic study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2020
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 27 May 2016 New trial record